BioSpace News Archive

Business

Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board

Microbot Medical Inc. announced that Irene Bargellini, M.D., an interventional radiologist and Chair of the Diagnostic and Interventional Radiology Department at Candiolo Cancer Institute in Turin, Italy, has joined the Company’s Scientific Advisory Board.

July 11, 2023
·
4 min read
Business

Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2

Bausch + Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter 2023 financial results on Wednesday, Aug. 2, 2023.

July 11, 2023
·
1 min read
Biotech Bay

CareDx’s AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring

CareDx, Inc. announced that CareDx’s AlloSure® Lung donor-derived cell-free DNA molecular testing service has received Medicare coverage.

July 11, 2023
·
6 min read
Business

Velocity and Privia Health Enter Partnership to Embed Clinical Research Into Practice Sites

Velocity Clinical Research, the leading multi-specialty clinical sites business, and Privia Health, a physician enablement company serving more than 3,700 providers and 4.4 million patients, announced a partnership to open embedded clinical research sites within Privia’s practice network.

July 11, 2023
·
3 min read
Business

Palatin Announces Preliminary Fourth Quarter Fiscal 2023 Vyleesi® Product Revenue Results

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced preliminary fiscal fourth quarter ended June 30, 2023 Vyleesi® product revenue results.

July 11, 2023
·
5 min read
Marvel Highlights Key Asset at the 2023 Alzheimer’s Association International Conference

Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), is pleased to announce that it has been selected to present the Company’s scientific advancement of its key asset MB-204 titled MB-204:

July 11, 2023
·
5 min read
Pharm Country

PDS Biotech Strengthens Intellectual Property Portfolio Governing A Combination of Versamune® and PDS0301

PDS Biotechnology Corporation announced the Canadian Intellectual Property Office has allowed patent number 2,876,656 titled, “Cationic Lipid Vaccine Combinations and Methods of Use,” governing composition of matter and uses for Versamune® in combination with PDS0301.

July 11, 2023
·
10 min read
Pharm Country

STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris

STRATA Skin Sciences, Inc. announced the Journal of Clinical and Aesthetic Dermatology published a review and an expert perspectives article in the June 2023 Supplemental edition titled, “Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris.”

July 11, 2023
·
4 min read
Drug Development

Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that patient enrollment has been completed in the Company’s Phase 2 clinical study of barzolvolimab for the treatment of chronic spontaneous urticaria (CSU).

July 11, 2023
·
6 min read
Business

Longeveron Appoints Dr. Nataliya Agafonova as Chief Medical OfficerExperienced Pharma Industry Clinical Operations Leader to Spearhead Development of Cellular Therapy Programs

Longeveron Inc. announced today the appointment of Nataliya Agafonova, M. D., as the Company’s Chief Medical Officer (CMO), effective as of July 1, 2023.

July 11, 2023
·
5 min read